Mediwave Life Sciences Private Limited
About Mediwave Life Sciences Private Limited
Data last updated:
Mediwave Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC134461. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vasantha Rao Kanaparthy (Managing Director) and Anitha Kanaparthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 12/A I – Floor Hema Nagar Road No.5 Boduppal, Hyderabad, Telangana, India – 500092.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.5 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹17.97 Lakh (net margin 5.1%) and EBITDA of ₹28.64 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address8 – 12/A I – Floor Hema Nagar Road No.5 Boduppal, Hyderabad, Telangana, India – 500092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mediwave Life Sciences Private Limited
The main business activity of Mediwave Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mediwave Life Sciences Private Limited FY 2025 filings available
Mediwave Life Sciences Private Limited reported revenue of ₹3.5 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mediwave Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 11% growth in the latest year. EBITDA rose 119% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mediwave Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹28.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.97 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mediwave Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mediwave Life Sciences are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mediwave Life Sciences Private Limited
Mediwave Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ranjana Healthcare Private Limited | ₹3.5 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Lucknow, Uttar Pradesh, India |
| Quimico Pharmaceuticals Private Limited | ₹3.5 Cr (FY 2024) | •••• | •••• | 50.0% | •••• | Jodhpur, Rajasthan, India |
| Allex Medical System Private Limited | ₹3.5 Cr (FY 2025) | •••• | •••• | •••• | Rajpura, Punjab, India | |
| Genip Pharmaceuticals Private Limited | ₹3.5 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Zeneris Pharma Private Limited | ₹3.5 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | New Delhi, Delhi, India |
| Mediwave Life Sciences Private Limited this company | ₹3.5 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
| DSK Medici Private Limited | ₹3.49 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Tirupur, Tamil Nadu, India |
| Thomas Baker (Biosciences) Private Limited | ₹3.48 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Dr. Brita Pharmaceutical Private Limited (OPC) | ₹3.48 Cr (FY 2025) | •••• | •••• | 533.0% | •••• | New Delhi, Delhi, India |
| Winsmed Pharmaceuticals Private Limited | ₹3.48 Cr (FY 2023) | •••• | •••• | 57.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Gupta Bros Druggist Private Limited | ₹3.47 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Mediwave Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Mediwave Life Sciences Private Limited
Mediwave Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vasantha Rao Kanaparthy Also directs: Lohitha Dharma Projects Private Limited | Managing Director | 30 Jul 2019 | 7 Years 2 Months | Current |
| Anitha Kanaparthy | Director | 29 Jan 2020 | 6 Years 8 Months | Current |
Ownership and Shareholding of Mediwave Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mediwave Life Sciences Private Limited
Mediwave Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mediwave Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Mediwave Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mediwave Life Sciences Private Limited
Mediwave Life Sciences Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Anitha Kanaparthy was appointed as Director on 29 Jan 2020.
Credit Ratings, Litigation & Regulatory Alerts for Mediwave Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mediwave Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mediwave Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mediwave Life Sciences Private Limited
Mediwave Life Sciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mediwave Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mediwave Life Sciences Private Limited
Mediwave Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 July 2019 (7+ years old) and is registered under CIN U51909TG2019PTC134461.
Mediwave Life Sciences reported revenue of ₹3.5 Cr for FY 2025 (up 11% YoY).
Mediwave Life Sciences has 2 current directors:
- Vasantha Rao Kanaparthy - Managing Director
- Anitha Kanaparthy - Director
Mediwave Life Sciences reported a net profit of ₹17.97 Lakh (net margin 5.1%) and EBITDA of ₹28.64 Lakh (EBITDA margin 8.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mediwave Life Sciences is 22% over three years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
No. Mediwave Life Sciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Mediwave Life Sciences is U51909TG2019PTC134461. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediwave Life Sciences was incorporated on 30 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Mediwave Life Sciences by revenue are Ranjana Healthcare Private Limited, Quimico Pharmaceuticals Private Limited, Allex Medical System Private Limited, Genip Pharmaceuticals Private Limited, Zeneris Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Anitha Kanaparthy was appointed as Director on 29 Jan 2020. Kiran Kumar Mamidala ceased to be Director on 29 Jan 2020. Vasantha Rao Kanaparthy was appointed as Managing Director on 30 Jul 2019.
The registered office of Mediwave Life Sciences is at 8 – 12A I – Floor Hema Nagar Road No.5 Boduppal, Hyderabad, Telangana, India – 500092.